ClinConnect ClinConnect Logo
Search / Trial NCT06005987

Mobile App Logging for Diabetes in Pregnancy

Launched by CAROLYN ZAHLER-MILLER · Aug 16, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Technology In Medicine Mobile Applications Blood Glucose Monitoring Diabetes In Pregnancy

ClinConnect Summary

This clinical trial is studying how using a mobile app to track blood sugar levels compares to using paper logs for pregnant women with diabetes. The goal is to see if the app helps women keep better track of their blood sugar levels, which is important for both their health and their baby's health. This study is open to women aged 18 and older who are at least 12 weeks pregnant and have been diagnosed with either gestational diabetes or type 2 diabetes.

If you decide to participate, you will be asked to monitor your blood sugar levels either through a mobile app or by using paper logs. The trial is currently recruiting participants, so if you meet the criteria and are interested, you can get involved. It's important to note that women who have type 1 diabetes or are already using a continuous glucose monitor or another app for tracking their glucose levels cannot participate. This trial could help improve diabetes management for pregnant women in the future!

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 18 years and older
  • Verified intrauterine pregnancy
  • At least 12 weeks gestation
  • Diagnosed with either type 2 diabetes mellitus or gestational diabetes mellitus.
  • Exclusion Criteria:
  • Patients with less than 4 weeks anticipated to be remaining in pregnancy
  • Pre-existing use of a continuous glucose monitor or other mobile application for glucose tracking
  • Type 1 diabetes mellitus
  • Non-English speaking patients

About Carolyn Zahler Miller

Carolyn Zahler-Miller is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the healthcare sector, she focuses on the strategic design and execution of clinical trials that adhere to rigorous ethical standards and regulatory compliance. Carolyn excels in fostering collaboration among multidisciplinary teams, ensuring that innovative therapies are rigorously evaluated for safety and efficacy. Her leadership is characterized by a patient-centered approach, prioritizing transparency and integrity throughout the research process.

Locations

Augusta, Georgia, United States

Patients applied

0 patients applied

Trial Officials

Rebecca Keipper, MD

Principal Investigator

Augusta University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported